La maladie de Parkinson au Canada (serveur d'exploration) - Checkpoint (Ncbi)

Index « Auteurs » - entrée « F E Parkinson »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
F E Griffiths < F E Parkinson < F F Casanueva  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 26.
[0-20] [0 - 20][0 - 26][20-25][20-40]
Ident.Authors (with country if any)Title
000019 (1998) S L Borgland [Canada] ; M. Casta N ; W. Spevak ; F E ParkinsonEffects of propentofylline on adenosine receptor activity in Chinese hamster ovary cell lines transfected with human A1, A2A, or A2B receptors and a luciferase reporter gene.
000033 (1999) C M Anderson [Canada] ; S A Baldwin ; J D Young ; C E Cass ; F E ParkinsonDistribution of mRNA encoding a nitrobenzylthioinosine-insensitive nucleoside transporter (ENT2) in rat brain.
000037 (1999) C M Anderson [Canada] ; W. Xiong ; J D Geiger ; J D Young ; C E Cass ; S A Baldwin ; F E ParkinsonDistribution of equilibrative, nitrobenzylthioinosine-sensitive nucleoside transporters (ENT1) in brain.
000071 (2000) C J Sinclair [Canada] ; P N Shepel ; J D Geiger ; F E ParkinsonStimulation of nucleoside efflux and inhibition of adenosine kinase by A1 adenosine receptor activation.
000109 (2000) F E Parkinson [Canada] ; Y W Zhang ; P N Shepel ; S C Greenway ; J. Peeling ; J D GeigerEffects of nitrobenzylthioinosine on neuronal injury, adenosine levels, and adenosine receptor activity in rat forebrain ischemia.
000120 (2000) C J Sinclair [Canada] ; C G Larivière ; J D Young ; C E Cass ; S A Baldwin ; F E ParkinsonPurine uptake and release in rat C6 glioma cells: nucleoside transport and purine metabolism under ATP-depleting conditions.
000154 (2001) C J Sinclair [Canada] ; L. Krizanac-Bengez ; K A Stanness ; D. Janigro ; F E ParkinsonAdenosine permeation of a dynamic in vitro blood-brain barrier inhibited by dipyridamole.
000192 (2001) C J Sinclair [Canada] ; A E Powell ; W. Xiong ; C G Larivière ; S A Baldwin ; C E Cass ; J D Young ; F E ParkinsonNucleoside transporter subtype expression: effects on potency of adenosine kinase inhibitors.
000252 (2002) F E Parkinson [Canada] ; C J D. Sinclair ; T. Othman ; N J Haughey ; J D GeigerDifferences between rat primary cortical neurons and astrocytes in purine release evoked by ischemic conditions.
000828 (1991) F E Parkinson [Canada] ; A S ClanachanAdenosine receptors and nucleoside transport sites in cardiac cells.
001D68 (2015) Y. Wang [Canada] ; Z. Zhou [Canada] ; T. Leylek [Canada] ; H. Tan [Canada] ; Y. Sun [Canada] ; F E Parkinson [Canada] ; J-F Wang [Canada]Protein cysteine S-nitrosylation inhibits vesicular uptake of neurotransmitters.
002033 (1989) F E Parkinson [Canada] ; A S ClanachanSubtypes of nucleoside transport inhibitory sites in heart: a quantitative autoradiographical analysis.
002153 (1989) F E Parkinson [Canada] ; A S ClanachanHeterogeneity of nucleoside transport inhibitory sites in heart: a quantitative autoradiographical analysis.
002406 (1995) J G Gu [Canada] ; I O Foga ; F E Parkinson ; J D GeigerInvolvement of bidirectional adenosine transporters in the release of L-[3H]adenosine from rat brain synaptosomal preparations.
002421 (1994) F E Parkinson [Canada] ; K A Rudolphi ; B B FredholmPropentofylline: a nucleoside transport inhibitor with neuroprotective effects in cerebral ischemia.
002487 (1993) F E Parkinson [Canada] ; A R Paterson ; J D Young ; C E CassInhibitory effects of propentofylline on [3H]adenosine influx. A study of three nucleoside transport systems.
002529 (1996) F E Parkinson [Canada] ; J D GeigerEffects of iodotubercidin on adenosine kinase activity and nucleoside transport in DDT1 MF-2 smooth muscle cells.
002530 (1996) F E Parkinson [Canada] ; B. Johansson ; K. Lindström ; B B FredholmAdenosine A1 and A2A receptors and nitrobenzylthioinosine-sensitive transporters in gerbil brain: no changes following long-term treatment with the adenosine transport inhibitor propentofylline.
002532 (1996) X. Fang [Canada] ; F E Parkinson ; D A Mowles ; J D Young ; C E CassFunctional characterization of a recombinant sodium-dependent nucleoside transporter with selectivity for pyrimidine nucleosides (cNT1rat) by transient expression in cultured mammalian cells.
002548 (1996) F E Parkinson [Canada] ; K. Mukherjee ; J D Geiger[3H]adenosine transport in DDT1 MF-2 smooth muscle cells: inhibition by metabolites of propentofylline.
002566 (1996) C M Anderson [Canada] ; D S Sitar ; F E ParkinsonAbility of nitrobenzylthioinosine to cross the blood-brain barrier in rats.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Ncbi/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i -k "F E Parkinson" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i  \
                -Sk "F E Parkinson" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Author.i
   |clé=    F E Parkinson
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022